Cargando…
Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages
Background: Breast cancer with osteoclast-like stromal giant cells (OSGC) is an exceedingly rare morphological pattern of invasive breast carcinoma. The tumor immune microenvironment (TIME) of these tumors is populated by OSGC, which resemble osteoclasts and show a histiocytic-like immunophenotype....
Autores principales: | Sajjadi, Elham, Gaudioso, Gabriella, Terrasi, Andrea, Boggio, Francesca, Venetis, Konstantinos, Ivanova, Mariia, Bertolasi, Letizia, Lopez, Gianluca, Runza, Letterio, Premoli, Alice, Lorenzini, Daniele, Guerini-Rocco, Elena, Ferrero, Stefano, Vaira, Valentina, Fusco, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462457/ https://www.ncbi.nlm.nih.gov/pubmed/36090031 http://dx.doi.org/10.3389/fmolb.2022.894247 |
Ejemplares similares
-
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling
por: Sajjadi, Elham, et al.
Publicado: (2021) -
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer
por: Lopez, Gianluca, et al.
Publicado: (2020) -
Improving HER2 testing reproducibility in HER2-low breast cancer
por: Sajjadi, Elham, et al.
Publicado: (2022) -
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
por: Sajjadi, Elham, et al.
Publicado: (2023) -
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
por: Porta, Francesca Maria, et al.
Publicado: (2023)